Synthesis and evaluation of sulfonamide derivatives as potent Human Uric Acid Transporter 1 (hURAT1) inhibitors

Bioorg Med Chem Lett. 2017 May 1;27(9):1919-1922. doi: 10.1016/j.bmcl.2017.03.041. Epub 2017 Mar 18.

Abstract

This letter presents synthesis and structure-activity relationship study of sulfonamide derivatives as inhibitors of Human Uric Acid Transporter 1 (hURAT1). Among all tested sulfonamide derivatives, compounds 9b, 16i and 19b exhibited excellent inhibition activity with IC50 value of 10, 2, and 83nM, respectively. In addition, compounds 9b and 19b demonstrated moderate PK profile in rats.

Keywords: Bioisostere; Gout disease; Pharmacokinetic studies; Structure-activity relationship; Sulfonamide; hURAT1 inhibitor.

MeSH terms

  • Animals
  • Gout / drug therapy
  • Gout / enzymology
  • Gout Suppressants / chemical synthesis
  • Gout Suppressants / chemistry*
  • Gout Suppressants / pharmacokinetics
  • Gout Suppressants / pharmacology*
  • Humans
  • Male
  • Organic Anion Transporters / antagonists & inhibitors*
  • Organic Anion Transporters / metabolism
  • Organic Cation Transport Proteins / antagonists & inhibitors*
  • Organic Cation Transport Proteins / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Structure-Activity Relationship
  • Sulfonamides / chemical synthesis
  • Sulfonamides / chemistry*
  • Sulfonamides / pharmacokinetics
  • Sulfonamides / pharmacology*

Substances

  • Gout Suppressants
  • Organic Anion Transporters
  • Organic Cation Transport Proteins
  • SLC22A12 protein, human
  • Sulfonamides